Richard P Junghans

This inventor holds 7 USPTO granted patents and 7 published patent applications and 4 EPO patents. Top assignees: Roger Williams Hospital, Prospect Charactercare Rwmc, LLC, Prospect Chartercare Rwmc, LLC. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard P Junghans. Retrieved from https://idiyas.com/inventor/richard-p-junghans

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7 (Patent Applications = 7)

% Patents Active = 28.6

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 35(Granted Patents)

Location History:

Providence, RI (US) (2015)
Boston, MA (US) (2017 - 2023)

Company Filing History:

2 out of 8

Roger Williams Hospital

patents

1 out of 1

Prospect Charactercare Rwmc, LLC

patent

1 out of 1

Prospect Chartercare Rwmc, LLC

patent

4. 1 out of 1

Prospect Chartercare, LLC

patent

5. 1 out of 3

Roger Williams Medical Center

Years Active: 2015-2023

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11624068 - Compositions and methods for improving immune system function (2023-04-11),

2. 10550176 - Viral vectors encoding multiple highly homologous non-viral polypeptides and the use of same (2020-02-04),

3. 10471098 - Hepatic arterial infusion of CAR-T cells (2019-11-12),

4. 10071118 - Compositions and methods for treating peritoneal cancers (2018-09-11),

5. 9833480 - Methods and compositions for treating HIV (2017-12-05),

6. 9650428 - Methods and compositions for treating cancer (2017-05-16),

7. 9206440 - Viral vectors encoding multiple highly homologus non-viral polypeptides and the use of same (2015-12-08),

Title: Innovations and Contributions of Richard P. Junghans

Introduction

Richard P. Junghans is a notable inventor based in Boston, MA, with a significant contribution to the field of immunotherapy. He holds a total of seven patents, showcasing his innovative approach to improving immune system function and developing advanced therapeutic methods.

Latest Patents

Among his latest patents is a composition and method for improving immune system function. This invention focuses on the use of YY1 and EZH2 inhibitors to prevent and reverse T-cell exhaustion, which is particularly relevant in the context of immunotherapy. Another significant patent involves viral vectors that encode multiple highly homologous non-viral polypeptides. This invention relates to the creation of vector nucleic acid sequences that comprise two or more exogenous nucleic acid sequences, which are designed to reduce homology while maintaining the encoded polypeptide sequence.

Career Highlights

Richard has worked with several prominent organizations, including Roger Williams Hospital and Prospect Chartercare, LLC. His work in these institutions has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical technology and patient care.

Collaborations

Richard has collaborated with notable professionals in his field, including Steven C. Katz and Wen Yang. These collaborations have likely enriched his research and development efforts, leading to impactful innovations.

Conclusion

Richard P. Junghans exemplifies the spirit of innovation in the medical field through his patents and collaborations. His work continues to influence the development of therapies aimed at enhancing immune system function.

Profile summary based on public USPTO records.